Literature DB >> 2754548

Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children.

B A Dennison1, D A Kikuchi, S R Srinivasan, L S Webber, G S Berenson.   

Abstract

We studied the relationship between parental history of cardiovascular disease and risk for adverse lipid and lipoprotein levels in a total community study of 3313 children (ages 4 to 17 years, 63% white, 37% black). Older white children (11 to 17 years) with a parental history of heart attack or diabetes were 4.3 and 5.6 times, respectively, more likely to have high levels (greater than or equal to 95th percentile) of serum total cholesterol than those without such a history (all p less than 0.05). White children with a parental history of heart attack or diabetes were twice as likely to have an elevated (greater than or equal to 95th percentile) low-density lipoprotein cholesterol (LDL-C) level than those without such a history (both p less than 0.05). In contrast, parental history of cardiovascular disease did not predict elevated levels of total cholesterol or LDL-C in black children. However, older black children with a parental history of heart attack, hypertension, or diabetes were 4 1/2 to 5 times more likely to have low levels (less than or equal to 5th percentile) of high-density lipoprotein cholesterol than those without such a history (all p less than 0.05). Only 40% of white children and 21% of black children with elevated LDL-C levels had a parental history of vascular disease. These findings raise questions about the current practice of screening only children with a family history of cardiovascular disease to identify those with elevated total cholesterol and LDL-C levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754548     DOI: 10.1016/s0022-3476(89)80063-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study.

Authors:  John A Morrison; Charles J Glueck; Ping Wang
Journal:  Metabolism       Date:  2011-10-14       Impact factor: 8.694

2.  Screening for familial hypercholesterolaemia by measurement of apolipoproteins in capillary blood.

Authors:  F Skovby; S Micic; B Jepsen; S O Larsen; B Hansen; L Tegllund; B N Pedersen
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

Review 3.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

4.  The child as proband for future parental cardiometabolic disease: the 26-year prospective Princeton Lipid Research Clinics Follow-up Study.

Authors:  John A Morrison; Charles J Glueck; Ping Wang
Journal:  J Pediatr       Date:  2012-01-13       Impact factor: 4.406

5.  Factors related to total cholesterol and blood pressure in British 9 year olds.

Authors:  R J Rona; S Qureshi; S Chinn
Journal:  J Epidemiol Community Health       Date:  1996-10       Impact factor: 3.710

6.  The next generation: poor compliance with risk factor guidelines in the children of parents with premature coronary heart disease.

Authors:  N R Langner; P C Rowe; R Davies
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

7.  Cholesterol screening and family history of vascular disease.

Authors:  E D Primrose; J M Savage; C A Boreham; G W Cran; J J Strain
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

8.  Risk factors for cardiovascular disease and type 2 diabetes retained from childhood to adulthood predict adult outcomes: the Princeton LRC Follow-up Study.

Authors:  John A Morrison; Charles J Glueck; Jessica G Woo; Ping Wang
Journal:  Int J Pediatr Endocrinol       Date:  2012-04-16

Review 9.  A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.

Authors:  Roya Kelishadi; Ali Akbar Haghdoost; Mahmood Moosazadeh; Mojtaba Keikha; Maryam Aliramezany
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.